Skip to main content
SpringerLink
Log in

Increased sucrose permeability in Behçet’s disease

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Behçet’s disease (BD) is a chronic, relapsing, systemic vasculitis with unknown etiology. During the progression of the disease, gastrointestinal involvement can be observed. The aim of this study was to find out the predictive value of the sucrose permeability test in detecting gastrointestinal mucosal damage in BD. Twenty-six male Behçet’s patients and 21 age- and sex-matched controls were enrolled in the study. Seventeen patients had active disease, while nine did not. Active disease was defined as having elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels or at least two of the diagnostic criteria in the previous month. Patients and controls were investigated with the upper gastrointestinal permeability test. Of all the patients, 25 were investigated endoscopically. The urine sucrose levels were significantly higher in patients than in the control group (P=0.0001) and in patients with active disease than those with inactive disease (P<0.0001), while urine sucrose of patients with inactive disease and the control group did not differ. The endoscopic findings were not specific to BD. Active and inactive BD had similar endoscopic findings. Increased upper gastrointestinal permeability was established in patients with BD. This increased permeability was not related to a specific gastrointestinal BD lesion. Further studies with larger series must be performed in order to determine the value of the sucrose permeability test in detecting mucosal involvement in BD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Abdullah AN, Keczkes K (1989) Behçet’s syndrome with gastro-intestinal tract involvement mimicking carcinoma of the caecum—a case report. Clin Exp Dermatol 14:459–461

    CAS  PubMed  Google Scholar 

  2. Feigenbaum A (1956) Description of Behçet’s syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol 40:355

    PubMed  Google Scholar 

  3. Behçet H (1937) Über rezidivierende Aphthose, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatologische Wochenschrift 105:1152

    Google Scholar 

  4. Mutlu S, Scully C (1994) The person behind the eponym: Hulusi Behçet (1889–1948). J Oral Pathol Med 23:289

    CAS  PubMed  Google Scholar 

  5. Yurdakul S, Tüzüner N, Yurdakul İ, Hamuryudan V, Yazıcı H (1996) Gastrointestinal involvement in Behçet’s syndrome: a controlled study. Ann Rheum Dis 55:208–210

    CAS  PubMed  Google Scholar 

  6. Anti M, Marra G, Rapaccini GL, Barone C, Manna R, Bochicchio GB, Fedeli G J (1986) Esophageal involvement in Behçet’s syndrome. J Clin Gastroenterol 8:514–519

    CAS  PubMed  Google Scholar 

  7. Powderly WG, Lombard MG, Murray FE, O’Connell D, Counihan TB, Lennon JR (1987) Oesophageal ulceration in Behçet’s disease presenting with haemorrhage. Ir J Med Sci 156:193–194

    PubMed  Google Scholar 

  8. Griffin JW Jr, Harrison HB, Tedesco FJ, Mills LR (1982) Behçet’s disease with multiple sites of gastrointestinal involvement. 4th South Med J 75:1405–1408

    Google Scholar 

  9. Hamuryudan V, Yurdakul S, Yazıcı H (1997) Behçet’s syndrome. Rheumatol Eur 26:31–33

    Google Scholar 

  10. De Keyser F, Elewaut D, De Vos M, De Viam K, Cuvelier C, Mielants H (1998) Bowel inflammation and the spondylarthropathies. Rheum Dis Clin North Am 24:785–813

    PubMed  Google Scholar 

  11. Bjarnason I, MacPherson A, Hollander D (1995) Intestinal permeability: an overview. Gastroenterology 108:1566–1581

    PubMed  Google Scholar 

  12. Meddings JB, Sutherland LR, Byles NI, Wallace JL (1993) Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 104:1619–1626

    CAS  PubMed  Google Scholar 

  13. Sutherland LR, Verhoef M, Wallace JL, Rosendal GV, Crutcher R, Meddings JB (1994) A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet 343:998–1000

    CAS  PubMed  Google Scholar 

  14. Simon DJ, Mike S, Peter WRG (2001) Intestinal permeability tests in coeliac disease. Clin Lab 47:143–150

    PubMed  Google Scholar 

  15. Smecuol E, Bai JC, Sugai E, Vazquez H, Niveloni S, Pedreira S, Maurino E, Meddings J (2001) Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut 49:650–655

    Article  PubMed  Google Scholar 

  16. Erlacher L, Wyatt J, Pflugbeil S, Koller M, Ullrich R, Vogelsang H, Smolen JS, Graninger W (1998) Sucrose permeability as a marker for NSAID-induced gastroduodenal injury. Clin Exp Rheumatol 16:69–71

    PubMed  Google Scholar 

  17. International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080

    PubMed  Google Scholar 

  18. Aydıntuğ O, Tokgöz G, Özoran K, Düzgün N, Gürler A, Tutak H (1995) Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet’s disease. Rheumatol Int 15:75–78

    PubMed  Google Scholar 

  19. Pronai L, Ichıkawa Y, Nakazawa H, Arımonı S (1991) Enhanced superoxide generation and the decreased superoxide scavenging activity of peripheral blood leukocytes in Behçet’s disease—effects of colchicine. Clin Exp Rheumatol 9:227–233

    CAS  PubMed  Google Scholar 

  20. Holmes EW (1997) Coupled enzymatic assay for the determination of sucrose. Anal Biochem 244:103–109

    Article  CAS  PubMed  Google Scholar 

  21. O’Duffy JD (1978) Summary of the International Symposium on Behçet’s Disease. J Rheumatol 5:229–233

    CAS  PubMed  Google Scholar 

  22. Yurdakul S (1997) Behçet sendromunun epidemiyolojisi. Aktüel Tıp Dergisi 2:66–67

  23. Bradbury AW, Milne AA, Murie JA (1994) Surgical aspects of Behçet’s disease. Br J Surg 81:1712–1721

    CAS  PubMed  Google Scholar 

  24. Shimuzu T, Ehrlich GE, Inaka G, Hayashi K (1979) Behçet disease (Behçet syndrome). Semin Arthritis Rheum 8:223–260

    CAS  PubMed  Google Scholar 

  25. Baker RD, Baker SS, La Rosa K (1995) Polarized caco-2 cells: effect of reactive oxygen metabolites on enterocyte barrier function. Dig Dis Sci 40:510–518

    CAS  PubMed  Google Scholar 

  26. Deitch EA, Morrison J, Berg R, Specian RD (1990) Effect of hemorrhagic shock on bacterial translocation, intestinal morphology and intestinal permeability in conventional and antibiotic contaminated rats. Crit Care Med 18:529–536

    CAS  PubMed  Google Scholar 

  27. Tepperman BL, Brown JF, Korolkiewicz R, Whittle BJ (1994) Nitric oxide synthase activity. Viability and cyclic GMP levels in rat colonic epithelial cells: effect of endotoxin challenge. J Pharmacol Exp Ther 271:1477–1482

    CAS  PubMed  Google Scholar 

  28. Adams RB, Planchon SM, Roche JK (1993) IFN-alpha modulation of epithelial barrier function: time course, reversibility and site of cytokine binding. J Immunol 150:2356–2363

    CAS  PubMed  Google Scholar 

  29. Kızıltaş S, Imeryüz N, Gürcan T, Sıva A, Saip S, Dumanbar A, Kalaycı C, Ulusoy NB (1998) Corticosteroid therapy augments gastroduodenal permeability to sucrose. Am J Gastroenterol 93:2420–2425

    Article  PubMed  Google Scholar 

  30. Bjarnason I (1997) The intestinal permeability barrier—what is measured, what does it mean? Falk Symposium 100:17–18

    Google Scholar 

  31. Fresko I, Hamuryudan V, Demir M, Hızlı N, Sayman H, Melikoğlu M, Tunç R, Yurdakul S, Yazici H (2001) Intestinal permeability in Behçet’s syndrome. Ann Rheum Dis 60:65–66

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Gulhane Military Medical Academy, Etlik-Ankara, Turkey 06018

    Bayram Koc, Serdar Aymelek, Alper Sonmez, M. Ilker Yilmaz & Hakki Kocar

Authors
  1. Bayram Koc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Serdar Aymelek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alper Sonmez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Ilker Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hakki Kocar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bayram Koc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koc, B., Aymelek, S., Sonmez, A. et al. Increased sucrose permeability in Behçet’s disease. Rheumatol Int 24, 347–350 (2004). https://doi.org/10.1007/s00296-003-0375-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-003-0375-3

Keywords

Search

Navigation